Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

889 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tumor sclerosis but not cell proliferation or malignancy grade is a prognostic marker in advanced-stage follicular lymphoma: the German Low Grade Lymphoma Study Group.
Klapper W, Hoster E, Rölver L, Schrader C, Janssen D, Tiemann M, Bernd HW, Determann O, Hansmann ML, Möller P, Feller A, Stein H, Wacker HH, Dreyling M, Unterhalt M, Hiddemann W, Ott G; German Low Grade Lymphoma Study Group. Klapper W, et al. Among authors: janssen d. J Clin Oncol. 2007 Aug 1;25(22):3330-6. doi: 10.1200/JCO.2006.10.5833. J Clin Oncol. 2007. PMID: 17664481
Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network.
Tiemann M, Schrader C, Klapper W, Dreyling MH, Campo E, Norton A, Berger F, Kluin P, Ott G, Pileri S, Pedrinis E, Feller AC, Merz H, Janssen D, Hansmann ML, Krieken H, Möller P, Stein H, Unterhalt M, Hiddemann W, Parwaresch R; European MCL Network. Tiemann M, et al. Among authors: janssen d. Br J Haematol. 2005 Oct;131(1):29-38. doi: 10.1111/j.1365-2141.2005.05716.x. Br J Haematol. 2005. PMID: 16173960 Free article.
Repp86: a new prognostic marker in mantle cell lymphoma.
Schrader C, Janssen D, Meusers P, Brittinger G, Siebmann JU, Parwaresch R, Tiemann M. Schrader C, et al. Among authors: janssen d. Eur J Haematol. 2005 Dec;75(6):498-504. doi: 10.1111/j.1600-0609.2005.00540.x. Eur J Haematol. 2005. PMID: 16313262 Clinical Trial.
AIDS-related B-cell lymphoma (ARL): correlation of prognosis with differentiation profiles assessed by immunophenotyping.
Hoffmann C, Tiemann M, Schrader C, Janssen D, Wolf E, Vierbuchen M, Parwaresch R, Ernestus K, Plettenberg A, Stoehr A, Fatkenheuer G, Wyen C, Oette M, Horst HA. Hoffmann C, et al. Among authors: janssen d. Blood. 2005 Sep 1;106(5):1762-9. doi: 10.1182/blood-2004-12-4631. Epub 2005 May 19. Blood. 2005. PMID: 15905193 Free article. Clinical Trial.
A 38-year history of natural-killer-cell lymphoma.
Schrader C, Janssen D, Kneba M, Lennert K. Schrader C, et al. Among authors: janssen d. N Engl J Med. 2004 Jan 22;350(4):418-9. doi: 10.1056/NEJM200401223500423. N Engl J Med. 2004. PMID: 14736941 No abstract available.
Impact of cranial radiotherapy on central nervous system prophylaxis in children and adolescents with central nervous system-negative stage III or IV lymphoblastic lymphoma.
Burkhardt B, Woessmann W, Zimmermann M, Kontny U, Vormoor J, Doerffel W, Mann G, Henze G, Niggli F, Ludwig WD, Janssen D, Riehm H, Schrappe M, Reiter A. Burkhardt B, et al. Among authors: janssen d. J Clin Oncol. 2006 Jan 20;24(3):491-9. doi: 10.1200/JCO.2005.02.2707. J Clin Oncol. 2006. PMID: 16421426 Clinical Trial.
889 results